LabCorp Announces First Single-Platform Test for COVID-19 And Flu

By Kelly Lienhard / September 8, 2020 at 5:28 PM
The Laboratory Corporation of American (LabCorp) introduced the first combined diagnostic test for COVID-19, influenza A/B and respiratory syncytial virus (RSV) on Tuesday (Sept. 8). The test is currently available to patients nationwide through health care providers, but LabCorp is awaiting FDA authorization for the combined test to be offered at-home through LabCorp’s Pixel platform. If the single-platform test is authorized by FDA to be used by individuals at home through Pixel by LabCorp, it will further ease the burden...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.